1. Home
  2. ARQT vs HWKN Comparison

ARQT vs HWKN Comparison

Compare ARQT & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$25.38

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$131.19

Market Cap

3.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
HWKN
Founded
2016
1938
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Chemicals
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.3B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ARQT
HWKN
Price
$25.38
$131.19
Analyst Decision
Strong Buy
Buy
Analyst Count
7
2
Target Price
$25.00
$200.00
AVG Volume (30 Days)
1.5M
158.3K
Earning Date
02-25-2026
01-28-2026
Dividend Yield
N/A
0.58%
EPS Growth
N/A
1.06
EPS
N/A
3.95
Revenue
$317,929,000.00
$1,063,104,000.00
Revenue This Year
$85.83
$14.22
Revenue Next Year
$30.72
$7.46
P/E Ratio
N/A
$32.98
Revenue Growth
129.21
11.65
52 Week Low
$11.13
$98.30
52 Week High
$31.77
$186.15

Technical Indicators

Market Signals
Indicator
ARQT
HWKN
Relative Strength Index (RSI) 37.28 28.60
Support Level $25.51 $148.09
Resistance Level $26.97 $154.87
Average True Range (ATR) 1.08 5.74
MACD -0.15 -2.43
Stochastic Oscillator 12.10 1.05

Price Performance

Historical Comparison
ARQT
HWKN

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

Share on Social Networks: